AARON L LUEBKE
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology BISMARCK, ND NPI 1699929281
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology ND Lilly USA, LLC All categories
General Payments — all program years on this page
$655.03
- Category: General Payments
- Program years: PY2018–2024
- Record count: 30
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $250.52 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $134.94 | 7 |
| Education | $115.58 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $115.58 | 1 |
| Octapharma USA, Inc. | $26.13 | 1 |
| EISAI INC. | $24.17 | 1 |
| Coherus Biosciences Inc. | $19.71 | 1 |
| ABBVIE INC. | $18.58 | 1 |
| PFIZER INC. | $17.76 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.56 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.03 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1101264287 | E.R. Squibb & Sons, L.L.C. | $14.03 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104910022 | ABBVIE INC. | $18.58 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1110726115 | Eisai Inc. | $24.17 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131425427 | PFIZER INC. | $17.76 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136002023 | Lilly USA, LLC | $115.58 | 12/02/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1142316592 | Octapharma USA, Inc. | $26.13 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144962046 | Takeda Pharmaceuticals U.S.A., Inc. | $14.56 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147274068 | Coherus Biosciences Inc. | $19.71 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.